174 related articles for article (PubMed ID: 2970029)
1. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis.
Luciano AA; Turksoy RN; Carleo J
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):323-7. PubMed ID: 2970029
[TBL] [Abstract][Full Text] [Related]
2. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
[TBL] [Abstract][Full Text] [Related]
3. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
Cedars MI; Lu JK; Meldrum DR; Judd HL
Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
[TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis.
Telimaa S; Puolakka J; Rönnberg L; Kauppila A
Gynecol Endocrinol; 1987 Mar; 1(1):13-23. PubMed ID: 2972167
[TBL] [Abstract][Full Text] [Related]
6. Treatment of endometriosis with leuprorelin acetate depot: a German multicentre study.
Gerhard I; Schindler AE; Bühler K; Winkler U; Meinen K; Mancarella D; Hoffmann G; Schüssler B; Kimmig R; Kranzfelder D
Clin Ther; 1992; 14 Suppl A():3-16. PubMed ID: 1535021
[TBL] [Abstract][Full Text] [Related]
7. [Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis].
Wang YQ; Zhang SF; Chen X; Zhu J; Hua KQ; Hu WG
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):504-8. PubMed ID: 19957549
[TBL] [Abstract][Full Text] [Related]
8. Management of endometriosis with oral medroxyprogesterone acetate.
Moghissi KS; Boyce CR
Obstet Gynecol; 1976 Mar; 47(3):265-7. PubMed ID: 1250555
[TBL] [Abstract][Full Text] [Related]
9. Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content.
Metzger DA; Lessey BA; Soper JT; McCarty KS; Haney AF
Obstet Gynecol; 1991 Nov; 78(5 Pt 2):946-50. PubMed ID: 1833687
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of endometriosis with the GnRH agonist buserelin (Suprecur): a multicenter study].
Schindler AE; Bühler K; Mettler L; Fuchs U; Cirkel U; Ochs H; Schweppe KW; Koch R
Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):569-73. PubMed ID: 8001754
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of endometriosis with the GnRH agonist leuprorelin acetate depot (Enatone-Gyn monthly depot): a multicenter study].
Schindler AE; Bühler K; Gerhard I; Wiedemann R; Kimmig R; Schüssler B; Kranzfelder D; Mall-Häfeli M; Meinen K; Mancarella D
Zentralbl Gynakol; 1994; 116(12):679-86. PubMed ID: 7846980
[TBL] [Abstract][Full Text] [Related]
12. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group.
Rock JA; Truglia JA; Caplan RJ
Obstet Gynecol; 1993 Aug; 82(2):198-205. PubMed ID: 8336864
[TBL] [Abstract][Full Text] [Related]
13. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
Vavra N; Salzer H; Sevelda P; Breitenecker G; Czerwenka K; Kucera H
Gynakol Rundsch; 1990; 30(3):133-43. PubMed ID: 2147161
[TBL] [Abstract][Full Text] [Related]
14. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
[TBL] [Abstract][Full Text] [Related]
15. Steroidal drugs in endometriosis.
Kauppila AJ; Telimaa S; Rönnberg L
Acta Obstet Gynecol Scand Suppl; 1989; 150():7-13. PubMed ID: 2533450
[TBL] [Abstract][Full Text] [Related]
16. Mild and moderate endometriosis. Comparison of treatment modalities for infertile couples.
Paulson JD; Asmar P; Saffan DS
J Reprod Med; 1991 Mar; 36(3):151-5. PubMed ID: 1827652
[TBL] [Abstract][Full Text] [Related]
17. [Ovarian suppression by the GnRH analog buserelin in the treatment of endometriosis. Clinical, biochemical and pelviscopic studies].
Raitz von Frentz M; Schweppe KW
Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):634-9. PubMed ID: 2145192
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience with danazol treatment of endometriosis and mastopathy].
Pavelka R; Schneider WH
Wien Klin Wochenschr; 1981 Oct; 93(19):595-9. PubMed ID: 6798763
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of endometriosis with domestic luteinizing hormone--releasing hormone analogue].
Geng L; Gu FY; Zhang LZ
Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):592-4, 636. PubMed ID: 7712871
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
Gregoriou O; Konidaris S; Vitoratos N; Papadias C; Papoulias I; Chryssicopoulos A
Int J Fertil Womens Med; 1997; 42(6):406-11. PubMed ID: 9459084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]